BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15008726)

  • 1. The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia.
    Kobelt G; Spångberg A; Mattiasson A
    BJU Int; 2004 Mar; 93(4):543-8. PubMed ID: 15008726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feedback microwave thermotherapy versus TURP for clinical BPH--a randomized controlled multicenter study.
    Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund J; Kroyer K; Ageheim H; Mattiasson A
    Urology; 2002 Aug; 60(2):292-9. PubMed ID: 12137829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study.
    Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund J; Kroyer K; Ageheim H; Mattiasson A
    Urology; 2004 Oct; 64(4):698-702. PubMed ID: 15491704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seeking evidence that cell kill guided thermotherapy gives results not inferior to those of transurethral prostate resection: results of a pooled analysis of 3 studies of feedback transurethral microwave thermotherapy.
    Gravas S; Laguna P; Ehrnebo M; Wagrell L; Mattiasson A; de la Rosette JJ
    J Urol; 2005 Sep; 174(3):1002-6; discussion 1006. PubMed ID: 16094023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Under what conditions is feedback microwave thermotherapy (ProstaLund Feedback Treatment) cost-effective in comparison with alpha-blockade in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms?
    Ragnarson Tennvall G; Hjelmgren J; Malmberg L
    Scand J Urol Nephrol; 2006; 40(6):495-505. PubMed ID: 17130102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis.
    De La Rosette JJ; Floratos DL; Severens JL; Kiemeney LA; Debruyne FM; Pilar Laguna M
    BJU Int; 2003 Nov; 92(7):713-8. PubMed ID: 14616453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: two-year follow-up.
    Waldén M; Acosta S; Carlsson P; Pettersson S; Dahlstrand C
    Scand J Urol Nephrol; 1998 May; 32(3):204-10. PubMed ID: 9689700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: a preliminary assessment of the Prostalund feedback treatment machine.
    Kehinde EO; Abul F
    Med Princ Pract; 2005; 14(4):272-6. PubMed ID: 15961940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia.
    Fowler C; McAllister W; Plail R; Karim O; Yang Q
    Health Technol Assess; 2005 Feb; 9(4):iii-iv, 1-30. PubMed ID: 15698525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feedback microwave thermotherapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, randomized, controlled, multicenter study.
    Schelin S; Geertsen U; Walter S; Spångberg A; Duelund-Jacobsen J; Krøyer K; Hjertberg H; Vatne V; Richthoff J; Nordling J
    Urology; 2006 Oct; 68(4):795-9. PubMed ID: 17070355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II--results.
    Blute M; Ackerman SJ; Rein AL; Beusterien K; Sullivan EM; Tanio CP; Strauss MJ; Manyak MJ
    Urology; 2000 Dec; 56(6):981-7. PubMed ID: 11113744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up.
    Gravas S; Laguna MP; de la Rosette JJ
    J Endourol; 2003 Aug; 17(6):425-30. PubMed ID: 12965071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Economic evaluation of treatment for benign prostatic hyperplasia--transurethral resection vs thermotherapy vs laser vaporization].
    Aizawa T; Mamiya Y; Namiki K; Okubo Y; Kim T; Arai Y; Ito T; Miki M; Tachibana M
    Nihon Hinyokika Gakkai Zasshi; 2002 Nov; 93(7):736-42. PubMed ID: 12494518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review.
    Hoffman RM; MacDonald R; Monga M; Wilt TJ
    BJU Int; 2004 Nov; 94(7):1031-6. PubMed ID: 15541122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part I-methods.
    Ackerman SJ; Rein AL; Blute M; Beusterien K; Sullivan EM; Tanio CP; Manyak MJ; Strauss MJ
    Urology; 2000 Dec; 56(6):972-80. PubMed ID: 11113743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement.
    Lourenco T; Armstrong N; N'Dow J; Nabi G; Deverill M; Pickard R; Vale L; MacLennan G; Fraser C; McClinton S; Wong S; Coutts A; Mowatt G; Grant A
    Health Technol Assess; 2008 Nov; 12(35):iii, ix-x, 1-146, 169-515. PubMed ID: 19032882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.